Pan-cancer analysis and KNSTRN as a potential prognosis biomarker

被引：0
|
作者：
Xiao, Shanshan [1 ]
Zou, Yuqing [1 ]
Wang, Li [1 ]
Wang, Qian [1 ]
Wang, Tao [1 ]
机构：
[1] Hangzhou Repugene Technol Co Ltd, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15180
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
    Zhong, Chenming
    Xie, Zijun
    Zeng, Ling-hui
    Yuan, Chunhui
    Duan, Shiwei
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] Pan-Cancer Analysis of CENPA as a Potential Prognostic and Immunological Biomarker in Human Cancer
    Hu, Zhongjiao
    Zhang, Shutao
    Yan, Xueling
    Zheng, Lulu
    Ding, Ke
    Liu, Shanshan
    Shi, Zheng
    [J]. CURRENT BIOINFORMATICS, 2022, 17 (07) : 599 - 614
  • [23] Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3
    Wu, Yinteng
    Zhang, Bo
    Nong, Juan
    Rodriguez, Raquel Alarcon
    Guo, Wenliang
    Liu, Ying
    Zhao, Shijian
    Wei, Ruqiong
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [24] Comprehensive pan-cancer analysis of ACSS3 as a biomarker for prognosis and immunotherapy response
    Zhang, Zhanzhan
    Yan, Hongshan
    Tong, Hao
    Guo, Kai
    Song, Zihan
    Jin, Qianxu
    Zhao, Zijun
    Zhao, Zongmao
    Shi, Yunpeng
    [J]. HELIYON, 2024, 10 (15)
  • [25] Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
    Liu, Jinhui
    Wang, Yuanyuan
    Yin, Jian
    Yang, Yan
    Geng, Rui
    Zhong, Zihang
    Ni, Senmiao
    Liu, Wen
    Du, Mulong
    Yu, Hao
    Bai, Jianling
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [26] Pan-cancer Analysis Identifies AIMP2 as a Potential Biomarker for Breast Cancer
    Qiu, Jie
    Zhou, Tao
    Wang, Danhong
    Hong, Weimin
    Qian, Da
    Meng, Xuli
    Liu, Xiaozhen
    [J]. CURRENT GENOMICS, 2023, 24 (05) : 307 - 329
  • [27] CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
    Yang, Kai
    Ma, Yan
    Chen, Weigang
    Liu, Lu
    Yang, Zelong
    He, Chaokui
    Zheng, Nanbei
    Liu, Xinyu
    Cheng, Xin
    Song, Junbo
    Chen, Yong
    Qiao, Hongyu
    Zhang, Ruohan
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [28] PRAME Is a Potential Carcinogenic Biomarker that Correlates with Patient Prognosis and Tumor Immunity Based on Pan-Cancer
    Zhao, Qi
    Zhang, Zhongwei
    Wu, Yinfang
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2022, 52 (02): : 185 - 195
  • [29] Pan-Cancer Analysis of Pentraxin 3: A Potential Biomarker of COVID-19
    Zhou, Zijian
    Zhou, Xuan
    Yang, Yuanyuan
    Wang, Lujia
    Wu, Zhong
    [J]. CANCERS, 2022, 14 (18)
  • [30] Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker
    Wang, Tiantian
    Rao, Dean
    Fu, Chenan
    Luo, Yiming
    Lu, Junli
    Liang, Huifang
    Xia, Limin
    Huang, Wenjie
    [J]. TRANSLATIONAL ONCOLOGY, 2024, 41
12345